Advertisement
News
Advertisement

Neurocrine plans to sell shares

Thu, 03/04/2010 - 12:17pm
The Associated Press

Biotechnology company Neurocrine Biosciences Inc. said on Thursday that it plans to sell shares in an underwritten public offering.

The book-runner will be Jefferies & Co.

The size and pricing for the offering have not yet been set. Neurocrine shares fell 3 cents to close at $2.60 on Thursday.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading